Related Experiment Video

Updated: Jul 7, 2026

Quantifying Agonist Activity at G Protein-coupled Receptors
11:45

Quantifying Agonist Activity at G Protein-coupled Receptors

Published on: December 26, 2011

Structure-activity relationship study and NMR analysis of fluorobenzoyl pentapeptide GPR54 agonists

Kenji Tomita1, Shinya Oishi, Hiroaki Ohno

  • 1Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan. kenjitomita@f01.mbox.media.kyoto-u.ac.jp

Biopolymers
|February 28, 2008
PubMed

Insights

This study identifies potent GPR54 agonists, specifically a 4-fluorobenzoyl pentapeptide derivative, for potential use in treating cancer metastasis and hormonal diseases. Fluorine substitution impacts GPR54 agonist conformation and binding affinity.

Area of Science:

  • Medicinal Chemistry
  • Endocrinology
  • Molecular Pharmacology

Background:

  • G-protein coupled receptor 54 (GPR54) plays a crucial role in cancer metastasis and endocrine regulation.
  • GPR54 activation influences carcinoma cell mobility and gonadotropin-releasing hormone secretion.
  • GPR54 agonists represent promising therapeutic agents for hormonal disorders and cancer metastasis.

Purpose of the Study:

  • To investigate the structure-activity relationship of N-terminally benzoyl-substituted pentapeptide derivatives as GPR54 agonists.
  • To determine the impact of fluorine substitution on the N-terminal benzoyl group on GPR54 binding affinity and agonist activity.

Main Methods:

  • Synthesis and evaluation of a series of pentapeptide derivatives with varying fluorine-substituted benzoyl groups.
  • Assessment of GPR54 binding affinity and agonist activity.
  • Nuclear Magnetic Resonance (NMR) spectroscopy to analyze peptide conformation.

Main Results:

  • A 4-fluorobenzoyl pentapeptide derivative emerged as the most potent GPR54 agonist.
  • Derivatives with multiple fluorine substituents exhibited reduced binding affinity.
  • NMR analysis indicated that fluorine substituents influence benzoyl conformation, with potential intramolecular hydrogen bonding in ortho-monofluorobenzoyl derivatives.

Conclusions:

  • The position and number of fluorine substituents on the N-terminal benzoyl group significantly modulate GPR54 agonist potency.
  • Conformational changes induced by fluorine substitution are critical for GPR54 interaction.
  • Optimized fluorinated pentapeptides hold potential for therapeutic development targeting GPR54-mediated pathways.

More Related Videos

Characterization of G Protein-coupled Receptors by a Fluorescence-based Calcium Mobilization Assay11:49

Characterization of G Protein-coupled Receptors by a Fluorescence-based Calcium Mobilization Assay

Published on: July 28, 2014

Modeling Ligands into Maps Derived from Electron Cryomicroscopy09:30

Modeling Ligands into Maps Derived from Electron Cryomicroscopy

Published on: July 19, 2024

Related Concept Videos

Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...